Active and passive smoking and risk of breast cancer: a meta-analysis Alina MacacuPhilippe AutierPeter Boyle Review 06 November 2015 Pages: 213 - 224
Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancer Andrew CiupekYassine RechoumSuzanne A. W. Fuqua Preclinical study 20 October 2015 Pages: 225 - 237
Optimal threshold for stromal tumor-infiltrating lymphocytes: its predictive and prognostic value in HER2-positive breast cancer treated with trastuzumab-based neoadjuvant chemotherapy Shiwei LiuXuening DuanYinhua Liu Preclinical study 26 October 2015 Pages: 239 - 249
Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancer Neha AggarwalAnn Marie SantiagoBonnie F. Sloane Preclinical study 26 October 2015 Pages: 251 - 262
Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover Steffi OesterreichN. Lynn HenryDavid A. Flockhart Preclinical study 04 November 2015 Pages: 263 - 273
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials Meredith M. ReganOlivia PaganiSOFT and TEXT Investigators and International Breast Cancer Study Group Clinical trial 22 October 2015 Pages: 275 - 286
Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor Kimberly BlackwellHoward BurrisSara M. Tolaney Clinical trial 24 October 2015 Pages: 287 - 297
A phase II trial of ixabepilone and cyclophosphamide as neoadjuvant therapy for patients with HER2-negative breast cancer: correlation of pathologic complete response with the 21-gene recurrence score Denise A. YardleyNancy W. PeacockJohn D. Hainsworth Clinical trial 27 October 2015 Pages: 299 - 308
Dose–response effects of aerobic exercise on estrogen among women at high risk for breast cancer: a randomized controlled trial Kathryn H. SchmitzNancy I. WilliamsJerene Good Clinical trial 28 October 2015 Pages: 309 - 318
A randomized controlled trial of cognitive-behavioral stress management in breast cancer: survival and recurrence at 11-year follow-up Jamie M. StaglSuzanne C. LechnerMichael H. Antoni Clinical trial 30 October 2015 Pages: 319 - 328
Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivors Wendy Demark-WahnefriedGraham A. ColditzENERGY Trial Group Clinical trial 31 October 2015 Pages: 329 - 337
Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer Jin Sun LeeMichelle E. MeliskoJohn W. Park Clinical trial 31 October 2015 Pages: 339 - 349
SOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer Antonio Llombart-CussacBegoña BermejoJose Baselga Clinical trial 04 November 2015 Pages: 351 - 357
Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors Adrienne G. WaksSara M. TolaneyLindsey R. Baden Epidemiology 29 September 2015 Pages: 359 - 367
Risk of breast cancer among patients with bioprosthetic or mechanical valve replacement: a population-based study in Sweden Jianguang JiBengt ZöllerKristina Sundquist Epidemiology 17 October 2015 Pages: 369 - 375
Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection Anna M. ChiarelliMaegan V. PrummelMartin J. Yaffe Epidemiology 30 October 2015 Pages: 377 - 387
Pre-diagnostic polyphenol intake and breast cancer survival: the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort Cecilie KyrøRaul Zamora-RosIsabelle Romieu Epidemiology 03 November 2015 Pages: 389 - 401
Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program Marisa BaréNúria ToràMaria Sala Epidemiology 03 November 2015 Pages: 403 - 415
Prescription drug coverage: implications for hormonal therapy adherence in women diagnosed with breast cancer Cathy J. BradleyBassam DahmanSarah Hawley Epidemiology 09 November 2015 Pages: 417 - 422
A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer Lei ZhangYe XuZicai Liang Brief Report 17 October 2015 Pages: 423 - 434
Doing “nothing” for DCIS: a case report Margo M. MoskosKevin S. Hughes Brief Report 26 October 2015 Pages: 435 - 437
Confocal laser endomicroscopy in breast surgery Giovanni D. De PalmaGaetano LuglioDario Esposito Letter to the Editor 24 October 2015 Pages: 439 - 439
